| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Hematology/Oncology, Department of Medicine, University of California at Los Angeles School of Medicine, Los Angeles, California 90024
Phorbol diesters induce macrophage-like differentiation in KG-1 and HL-60 human acute myelogenous leukemia cell lines. We developed a cloned subline of KG-1, known as KG-1a, that does not differentiate when exposed to phorbol diesters. Both KG-1 and KG-1a cells have a single class of specific high-affinity receptors for labeled phorbol-12,13-dibutyrate with a mean Kd of 1.47 ± 0.10 (S.E.) x 10-8 M and 0.85 ± 0.20 x 10-8 M for the sensitive parental KG-1 line and the resistant KG-1a subline, respectively (p < 0.025). The number of [3H]phorbol-12,13-dibutyrate binding sites (mean ± S.E.) per cell was 3.85 ± 0.98 x 105 and 3.94 ± 0.31 x 105 on KG-1 and resistant KG-1a cells, respectively. We observed no significant decrease of specific binding with time (down regulation) in either KG-1, KG-1a, or HL-60 cells, suggesting that down regulation of specific phorbol-12,13-dibutyrate binding is not critical to induction of differentiation. Our data also confirm that the presence of specific highaffinity phorbol receptors on leukemic cells does not assure that phorbol diesters can trigger their differentiation.
1 Recipient of grants from the NIH (CA 30526) and the USPHS. To whom requests for reprints should be addressed, at Division of Hematology/Oncology, Department of Medicine, 37-068 CHS, Los Angeles, Calif. 90024.
2 Recipient of support from the NIH (Grants CA 26038 and CA 32737); the Leukemia Society of America, Inc.; the Bruce Fowler, Jr., Memorial Fund; and the Jonsson Comprehensive Cancer Center. Scholar of the Leukemia Society of America.
Received 9/29/82. Accepted 5/ 3/83.
This article has been cited by other articles:
![]() |
D. C. St. Louis, J. B. Woodcock, G. Fransozo, P. J. Blair, L. M. Carlson, M. Murillo, M. R. Wells, A. J. Williams, D. S. Smoot, S. Kaushal, et al. Evidence for Distinct Intracellular Signaling Pathways in CD34+ Progenitor to Dendritic Cell Differentiation from a Human Cell Line Model J. Immunol., March 15, 1999; 162(6): 3237 - 3248. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |